Clinical Trials Directory

Trials / Completed

CompletedNCT03470532

Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction

Comparing the Effect of 4% Articaine and 2% Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction- A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Melaka Manipal Medical College · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study compares the the efficacy of buccal infiltration of 4% Articaine and 2% Mepivacaine without any palatal injection during extraction of maxillary teeth. One group of patient receives buccal infiltration of Articaine and another group receives buccal infiltration of Mepivacaine.

Detailed description

Dense local anesthesia is required to reduce pain during extraction of tooth. Administration of local anesthesia to the palatal mucosa is proved to be the most painful due to its firm adherence to the underlying periosteum and also it's abundant nerve supply. Articaine has greater lipid solubility and high bone penetration property. Mepivacaine is proven to be the safest local anaesthetic agent. Avoidance of a palatal injection during extraction will benefit the patient by reducing pain and anxiety to a greater extent. So this study compares the bone penetration property between Articaine and Mepivacaine by assessing the pain in the palatal mucosa while extracting the tooth using only buccal infiltration.

Conditions

Interventions

TypeNameDescription
DRUGbuccal infiltration of 4% Articaine with EpinephrineArticaine Hydrochloride 4 % / Epinephrine 1:200,000 1.8 ML Cartridge
DRUGbuccal infiltration of 2% Mepivacaine with EpinephrineMepivacaine Hydrochloride 2% Epinephrine 1:200,000 2.2 Ml Cartridge

Timeline

Start date
2017-02-25
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2018-03-20
Last updated
2018-03-21

Locations

1 site across 1 country: Malaysia

Regulatory

Source: ClinicalTrials.gov record NCT03470532. Inclusion in this directory is not an endorsement.